|
|
||||||||
1 oligodeoxynucleotides reduces
kidney weight and matrix mRNAs in diabetic mice
Renal-Electrolyte and Hypertension Division and Penn Center for Molecular Studies of Kidney Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6144
Inhibition of
gene expression by antisense oligodeoxynucleotides (ODNs) relies on
their ability to bind complementary mRNA sequences and prevent
translation. The proximal tubule is a suitable target for ODN therapy
in vivo because circulating ODNs accumulate in the proximal tubule in
high concentrations. Because increased proximal tubular transforming
growth factor-
1 (TGF-
1) expression may mediate diabetic renal
hypertrophy, we investigated the effects of antisense TGF-
1 ODN on
the high-glucose-induced proximal tubular epithelial cell hypertrophy
in tissue culture and on diabetic renal hypertrophy in vivo. Mouse
proximal tubular cells grown in 25 mM D-glucose and exposed
to sense ODN as control (1 µM) exhibited increased
3[H]leucine incorporation by 120% and total
TGF-
1 protein by 50% vs. culture in 5.5 mM D-glucose.
Antisense ODN significantly decreased the high-glucose-stimulated
TGF-
1 secretion and leucine incorporation. Continuous infusion for
10 days of ODN (100 µg/day) was achieved via osmotic minipumps in
diabetic and nondiabetic mice. Sense ODN-treated
streptozotocin-diabetic mice had 15.3% increase in kidney weight, 70%
increase in
1(IV) collagen and 46% increase in fibronectin mRNA
levels compared with nondiabetic mice. Treatment of diabetic mice with
antisense ODN partially but significantly decreased kidney TGF-
1
protein levels and attenuated the increase in kidney weight and the
1(IV) collagen and fibronectin mRNAs. In conclusion, therapy with
antisense TGF-
1 ODN decreases TGF-
1 production and attenuates
high-glucose-induced proximal tubular cell hypertrophy in vitro and
partially prevents the increase in kidney weight and extracellular
matrix expression in diabetic mice.
transforming growth factor-
1; nephropathy; proximal tubule; glucose; collagen type IV; fibronectin; osmotic mini-pumps
This article has been cited by other articles:
![]() |
B. Shen, M. Hagiwara, Y.-Y. Yao, L. Chao, and J. Chao Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress Hypertension, May 1, 2008; 51(5): 1358 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Tian, D. Fraser, L. Attisano, and A. O. Phillips TGF-{beta}1-mediated alterations of renal proximal tubular epithelial cell phenotype Am J Physiol Renal Physiol, July 1, 2003; 285(1): F130 - F142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Dahly, K. M. Hoagland, A. K. Flasch, S. Jha, S. R. Ledbetter, and R. J. Roman Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R757 - R767. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Eddy Plasminogen activator inhibitor-1 and the kidney Am J Physiol Renal Physiol, August 1, 2002; 283(2): F209 - F220. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Zhang, C. To, X. Chen, J. G. Filep, S.-S. Tang, J. R. Ingelfinger, and J. S. D. Chan Essential Role(s) of the Intrarenal Renin-Angiotensin System in Transforming Growth Factor-{beta}1 Gene Expression and Induction of Hypertrophy of Rat Kidney Proximal Tubular Cells in High Glucose J. Am. Soc. Nephrol., February 1, 2002; 13(2): 302 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hua, H. J. Goldberg, I.G. Fantus, and C. I. Whiteside High Glucose-Enhanced Mesangial Cell Extracellular Signal-Regulated Protein Kinase Activation and {alpha}1(IV) Collagen Expression in Response to Endothelin-1: Role of Specific Protein Kinase C Isozymes Diabetes, October 1, 2001; 50(10): 2376 - 2383. [Abstract] [Full Text] |
||||
![]() |
M. Zeisberg, G. Bonner, Y. Maeshima, P. Colorado, G. A. Muller, F. Strutz, and R. Kalluri Renal Fibrosis : Collagen Composition and Assembly Regulates Epithelial-Mesenchymal Transdifferentiation Am. J. Pathol., October 1, 2001; 159(4): 1313 - 1321. [Abstract] [Full Text] |
||||
![]() |
A. S. D. VRIESE, R. G. TILTON, M. ELGER, C. C. STEPHAN, W. KRIZ, and N. H. LAMEIRE Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes J. Am. Soc. Nephrol., May 1, 2001; 12(5): 993 - 1000. [Abstract] [Full Text] |
||||
![]() |
M. ISONO, M. C. I.-D. L. CRUZ, S. CHEN, S. W. HONG, and F. N. ZIYADEH Extracellular Signal-Regulated Kinase Mediates Stimulation of TGF-{beta}1 and Matrix by High Glucose in Mesangial Cells J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2222 - 2230. [Abstract] [Full Text] |
||||
![]() |
A.O. Phillips Diabetic nephropathy--where next? QJM, October 1, 2000; 93(10): 643 - 646. [Full Text] [PDF] |
||||
![]() |
S. H. Park and H. J. Han The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells Am J Physiol Renal Physiol, February 1, 2002; 282(2): F228 - F237. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |